Preview complete
The prescreener preview is complete. You may now close the preview.
AI-powered
SEEKING COVID POSITIVE VOLUNTEERS Development of Immunity After SARS-COV Exposure and Recovery (DISCOVER)
Study on Immunity Markers in COVID-19 Positive Individuals
Recruiting
100 years or below
All
Phase
N/A
1 Location
Brief description of study.
Researchers at the Indiana University School of Medicine are studying COVID-19 and are seeking individuals who have been clinically diagnosed as COVID positive.
Detailed description of study
The study will ask you several questions about your health, current medications and your COVID-19 status/exposure.
Blood samples and data will be collected four times:
- now
- again in 2-5 months
- again in 8-14 months
- and a final time in 18-24 months
You will be paid $25 for each blood draw.
We will be testing the blood samples for antibodies and other immunity markers.
You will be informed of the results of the antibody tests.
Learn more via this video:
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: covid,covid19,covid-19,corona,coronavirus,blood,antibody,antibodies,positive,postiive test,covid 19,corona virus,virus,covid 19,corona virus,virus,covid 19,corona virus,virus
-
Age: 100 years or below
-
Gender: All
Eligibility Criteria:
- Must have been clinically tested positive for COVID-19
Updated on
19 Feb 2024.
Study ID: 2004405708 - POS
This study investigates COVID-19 by analyzing blood samples from individuals who have been clinically diagnosed as COVID-19 positive. COVID-19, also known as coronavirus disease 2019, is an infectious disease caused by the SARS-CoV-2 virus. Researchers aim to understand the immune response in those who have been infected.
Participants will be asked questions about their health, medications, and COVID-19 status. Blood samples will be collected four times over the study period. These samples will be tested for antibodies and other markers of immunity. Participants will be informed about their antibody test results.
- Who can participate: Individuals who have been clinically tested positive for COVID-19 can join the study.
- Study details: Participants will answer questions about their health and provide blood samples. Each blood draw will be compensated with $25. The study will test blood samples for antibodies and other immunity markers.
Pre-Screener
